DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ASP-3026
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms
ALK tyrosine kinase receptor inhibitor
ASP-3026
×
Maximum Phase:
1
First Approval:
None
UNII:
HP4L6MXF10
Molecule Type:
Small molecule
Molecular Formula:
C29H40N8O3S
Molecular Weight:
580.76
AlogP:
3.77
PSA:
115.82
HBD:
2.0
HBA:
#RotB:
9.0
Source:
UAB-30
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Intraductal, Noninfiltrating
Unknown
UAB-30
×
Maximum Phase:
1
First Approval:
None
UNII:
PFP09575EX
Molecule Type:
Small molecule
Molecular Formula:
C20H22O2
Molecular Weight:
294.39
AlogP:
4.94
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04995274
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant
Unknown
PF-04995274
×
Maximum Phase:
1
First Approval:
None
UNII:
XI179PG9LV
Molecule Type:
Small molecule
Molecular Formula:
C23H32N2O6
Molecular Weight:
432.52
AlogP:
2.63
PSA:
86.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BETA-CARYOPHYLLENE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BETA-CARYOPHYLLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
BHW853AU9H
Molecule Type:
Small molecule
Molecular Formula:
C15H24
Molecular Weight:
204.36
AlogP:
4.73
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
RESOLVIN E1
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RESOLVIN E1
×
Maximum Phase:
1
First Approval:
None
UNII:
GND3JH08JA
Molecule Type:
Small molecule
Molecular Formula:
C20H30O5
Molecular Weight:
350.46
AlogP:
2.91
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
TELENZEPINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TELENZEPINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0990EG3K10
Molecule Type:
Small molecule
Molecular Formula:
C19H22N4O2S
Molecular Weight:
370.48
AlogP:
2.53
PSA:
55.89
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ELIMUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Neoplasms; Ovarian Neoplasms
Serine-protein kinase ATR inhibitor
ELIMUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
7N13IK9LNH
Molecule Type:
Small molecule
Molecular Formula:
C20H21N7O
Molecular Weight:
375.44
AlogP:
2.65
PSA:
84.75
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DS-3078A
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Serine/threonine-protein kinase mTOR inhibitor
DS-3078A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMOTAXEL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMOTAXEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E1M30YOE59
Molecule Type:
Small molecule
Molecular Formula:
C46H57NO15S
Molecular Weight:
896.02
AlogP:
4.67
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
11.0
Source:
H-100
1
Small molecule
Investigational
Unknown
Unknown
Penile Induration
Unknown
H-100
×
Maximum Phase:
1
First Approval:
None
UNII:
5RQ73K2EC8
Molecule Type:
Small molecule
Molecular Formula:
C11H11N3O3
Molecular Weight:
233.23
AlogP:
0.44
PSA:
102.22
HBD:
3.0
HBA:
#RotB:
5.0
Source:
HKI-357
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HKI-357
×
Maximum Phase:
1
First Approval:
None
UNII:
39R3638KZ6
Molecule Type:
Small molecule
Molecular Formula:
C31H29ClFN5O3
Molecular Weight:
574.06
AlogP:
6.68
PSA:
99.51
HBD:
2.0
HBA:
#RotB:
11.0
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BLI-489
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BLI-489
×
Maximum Phase:
1
First Approval:
None
UNII:
R56JYB8P8Z
Molecule Type:
Small molecule
Molecular Formula:
C13H11N3O4S
Molecular Weight:
305.31
AlogP:
0.64
PSA:
84.66
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CLX-0921
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
CLX-0921
×
Maximum Phase:
1
First Approval:
None
UNII:
4LXSR6QYJI
Molecule Type:
Small molecule
Molecular Formula:
C28H25NO7S
Molecular Weight:
519.58
AlogP:
5.1
PSA:
100.16
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TAS0612
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
p90RSK inhibitor
TAS0612
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H36F3N9O
Molecular Weight:
571.65
AlogP:
4.4
PSA:
119.79
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RX-5902
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-5902
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ACT-462206
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACT-462206
×
Maximum Phase:
1
First Approval:
None
UNII:
64ONO62P28
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O4S
Molecular Weight:
388.49
AlogP:
3.1
PSA:
75.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell; Photochemotherapy; Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
IMD-2560
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-2560
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SNS-314
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
SNS-314
×
Maximum Phase:
1
First Approval:
None
UNII:
802IFJ0Z8X
Molecule Type:
Small molecule
Molecular Formula:
C18H15ClN6OS2
Molecular Weight:
430.95
AlogP:
4.52
PSA:
95.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CEVIPABULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CEVIPABULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
P14M0DWS2J
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClF5N6O
Molecular Weight:
464.83
AlogP:
4.07
PSA:
76.37
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LB-102
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
LB-102
×
Maximum Phase:
1
First Approval:
None
UNII:
N81WKW91XF
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O4S
Molecular Weight:
383.51
AlogP:
1.74
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ARM-210
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ARM-210
×
Maximum Phase:
1
First Approval:
None
UNII:
1033GN605L
Molecule Type:
Small molecule
Molecular Formula:
C18H19NO3S
Molecular Weight:
329.42
AlogP:
3.5
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NORLEUCINE
1
Small molecule
Investigational
Unknown
Unknown
Hot Flashes; Malaria
Unknown
NORLEUCINE
×
Maximum Phase:
1
First Approval:
None
UNII:
832C8OV84S
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.59
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SEL-120
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SEL-120
×
Maximum Phase:
1
First Approval:
None
UNII:
SDM3M518PJ
Molecule Type:
Small molecule
Molecular Formula:
C15H18Br2N4
Molecular Weight:
414.14
AlogP:
3.23
PSA:
33.09
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CRS-3123
1
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections; Colitis; Infections
Methionine--tRNA ligase inhibitor
CRS-3123
×
Maximum Phase:
1
First Approval:
None
UNII:
2P987FW4E8
Molecule Type:
Small molecule
Molecular Formula:
C19H19Br2N3O2S
Molecular Weight:
513.26
AlogP:
5.03
PSA:
66.15
HBD:
3.0
HBA:
#RotB:
6.0
Source:
1
2
…
78
79
80
81
82
83
84
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA